Skip to main content
. 2022 Jun 15;9:910811. doi: 10.3389/fcvm.2022.910811

TABLE 1.

Pre-operative characteristics after PS-matching.

Total (2018) Non-CR (1009) CR (1009) P-value
Baseline characteristics
Age years [median (IQR)] 70 (64–76) 70 (64–76) 70 (64–76) 0.792
Male gender 1589 (78.7) 795 (78.8) 794 (78.7) 0.99
EuroSCORE II 1.91 (1.21,3.19) 1.92 (1.22, 3.19) 1.90 (1.18, 3.19) 0.760
Diabetes 899 (44.5) 457 (45.3) 442 (43.8) 0.531
Insulin ± oral hypoglycemic drugs 372 (18.4) 186 (18.4) 186 (18.4) 0.99
Smoking 1247 (61.8) 628 (62.2) 619 (61.3) 0.714
Hypertension 1829 (90.6) 917 (90.9) 912 (90.4) 0.760
Hyperlipidemia 1293 (64.1) 656 (65.0) 637 (63.1) 0.404
BMI [median (IQR)] 28.69 (25.78–31.70) 28.70 (25.65, 31.71) 28.69 (25.95, 31.67) 0.815
Pulmonary hypertensiona 154 (7.6) 86 (8.5) 68 (6.7) 0.154
Renal impairment 1128 (55.9) 570 (56.5) 558 (55.3) 0.622
Dialysis (regardless of CC) 26 (1.3) 13 (1.3) 13 (1.3) 0.99
Peripheral artery disease 515 (25.5) 263 (26.1) 252 (25.0) 0.610
Cerebrovascular disease 162 (8) 75 (7.4) 87 (8.6) 0.368
History of stroke 73 (3.6) 34 (3.4) 39 (3.9) 0.634
History of TIA/RIND 72 (3.6) 28 (2.8) 44 (4.4) 0.071
chronic lung disease 111 (5.5) 56 (5.6) 55 (5.5) 0.99
LVEF (%) [median (IQR)]a 50 (40–55) 50 (40–55) 49 (40–55) 0.527
3 vessel CAD 1609 (79.7) 813 (80.6) 796 (78.9) 0.376
Previous MI 1076 (53.3) 517 (51.2) 559 (55.4) 0.067
Previous PCI 304 (15.1) 152 (15.1) 152 (15.1) 0.99
NYHA IV 31 (1.5) 14 (1.4) 17 (1.7) 0.718
CCS 4 194 (9.6) 93 (9.2) 101 (10.0) 0.597
ACS 95 (4.7) 47 (4.7) 48 (4.8) 0.99

aMissing data.

PS, propensity score; IQR, interquartile range; BMI, body mass index; PA, pulmonary artery; CC, creatinine clearance; TIA, transient ischemic attack; LVEF, left ventricle ejection fraction; CAD, coronary artery disease; VD, vessel disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society; ACS, Acute Coronary Syndrome.